Delivery Order SPE2DB20D1100-SPE2DB25FE6S4
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,410.43 for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price structure. The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL insulin with a ceiling value of $8,157.52 under a firm fixed-price contract. This non-competitive delivery order was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of NovoLog 100 Unit/mL insulin vials (10mL) with a contract ceiling value of $1,476.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 14, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,463.19 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL insulin on May 6, 2025, with completion scheduled for May 7, 2025. This delivery order represents a non-competitive, non-set-aside award under a firm fixed-price contract structure. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,701.76 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,098.75 firm fixed price delivery order for NovoLog 100 Unit/mL vials (10 mL) with an ultimate completion date of June 3, 2025. This contract represents a non-set-aside, competitively awarded procurement executed on June 2, 2025, with performance to be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,770.97 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes treatment. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $4,938.18 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,432.44 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL), an insulin medication commonly used for diabetes management. This firm fixed-price, competitively awarded contract was issued on June 5, 2025, with an ultimate completion date of June 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,696.30 for NovoLog 100 Unit/ML vials (10 mL) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...